SPX5,638.94+117.42 2.13%
DIA415.36+6.58 1.61%
IXIC17,754.09+451.07 2.61%

FDA: BARD PERIPHERAL VASCULAR LETTER FOR ROTAREX ATHERECTOMY SYSTEMS RELATED TO POTENTIALLY HIGH-RISK DEVICE ISSUE

Reuters·02/06/2025 16:21:19
Listen to the news
FDA: BARD PERIPHERAL VASCULAR LETTER FOR ROTAREX ATHERECTOMY SYSTEMS RELATED TO POTENTIALLY HIGH-RISK DEVICE ISSUE